BORTEZOMIB J Code: J9041
Injection, bortezomib, 0.1 mg
Q4 2026 Medicare Payment Limit for J9041, effective October 1, 2026: $2.628 per HCPCS billing unit, up 29.0% from $2.037. From CMS's final file.
Drug & Product Overview
About BORTEZOMIB
Bortezomib is a medication aligned to the HCPCS J Code: J9041 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous or subcutaneous routes and manufactured by multiple companies.
According to CMS Drug Use Information: This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. Showing 5 of 22 NDCs — log in for the full crosswalk.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 00143-9098-01 | bortezomib | Hikma Pharmaceuticals USA Inc. | 35 | 3.5 MG |
| 00409-1700-01 | Bortezomib | Hospira, Inc. | 35 | 3.5 MG |
| 10019-0991-01 | Bortezomib | Baxter Healthcare Corporation | 35 | 3.5 MG |
| 25021-0244-10 | Bortezomib | Sagent Pharmaceuticals | 35 | 3.5 MG |
| 43598-0426-60 | Bortezomib | Dr.Reddy'S Laboratories, Inc. | 35 | 3.5 MG |
| •••••-••••-•• Log in to view | BORTEZOMIB | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | BORTEZOMIB | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | BORTEZOMIB | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
BORTEZOMIB Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →Bortezomib 505(b)(2) Information:
| HCPCS Code | Manufacturer | Active Ingredient | HCPCS Description |
|---|---|---|---|
| J9041 | Generic Code (Multiple Manufacturers) | Bortezomib | Injection, bortezomib, 0.1 mg |
| J9046 | Dr Reddy's Laboratories, Inc | Bortezomib | Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg |
| J9048 | Fresenius Kabi | Bortezomib | Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg |
| J9049 | Hospira | Bortezomib | Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg |
| J9051 | Fosun Pharma | Bortezomib | Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg |
| J9054 Log in to view | Amneal Biosciences Log in to view | Bortezomib Log in to view | Injection, bortezomib (boruzu), 0.1 mg Log in to view |
BORTEZOMIB Claims Performance
Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.
Explore J9041 claims analytics on FocalPoint →
BORTEZOMIB CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96401 | Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic |
| 96409 | Chemotherapy administration; intravenous, push technique, single or initial substance/drug |
| 96413 Login for More | Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug Login for More |
| 96415 Login for More | Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) Login for More |
CMS has identified Bortezomib (J9041) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →
BORTEZOMIB Medically Unlikely Edits (MUE)
The most billing units of J9041 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
BORTEZOMIB Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Bortezomib billing and coding guide?
Are there any available Bortezomib patient assistance programs?
Where can I find Bortezomib prescribing information?
Where can I find Bortezomib side effect information?
Does billing BORTEZOMIB require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to BORTEZOMIB.